Page results
-
UCLH is to trial a COVID-19 vaccine developed by Imperial College London.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
Today is the 72 anniversary of the NHS – and it is dedicated to our amazing staff.
-
UCLH will be part of a first-of-its kind clinical trial, led by scientists at UCL, that will evaluate the use of ‘real time’ viral genomic data to reduce the spread of COVID-19 within hospitals.
-
UCLH chair Baroness Julia Neuberger has today announced that Professor Marcel Levi will be stepping down from his role as UCLH chief executive on 31 March 2021.
-
UCLH has retendered and awarded five-year contracts to two companies to provide estates and facilities services across UCLH.
-
Researchers from UCLH, UCL and the University of East Anglia have highlighted the need to identify, test and isolate healthcare workers who experience a new loss of taste or smell (anosmia).
-
The comprehensive review, co-authored by UCLH Director of Research Prof Bryan Williams, recommends approaches including mindfulness practices and reducing exposure to air polluion.
-
Read about a new study which highlights the needs to increase support for stroke survivors
-
Using Art to Amplify Young People's Voices in Healthcare
File results
-
FOI/2024/0061 - 24 hour waits at A&E from 2019 to 2023
-
FOI/2024/0066 - Amputations due to medical errors 2020-2023
-
FOI/2024/0067 - Thornbury Nursing Services - January 2023 to December 2024
-
FOI/2024/0068 - Pilots of virtual wards remote monitoring solutions
-
FOI/2024/0069 - Staff bank contact details
-
FOI/2024/0078 - Locally employed doctors at Trust
-
FOI/2024/0081 - Consultant doctors headcount
-
FOI/2024/0092 - Decision to cease Salvage RARP with nerve spare in 2023
-
FOI/2024/0095 - Hospital at home - Discharge and discharge to assess pathways
-
FOI/2024/0097 - Laboratory Information Management System (LIMS)/ pathology IT system